Metraipolis › archive › dc_fcff41cee85d

The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes — Europe PMC PMID:41353143

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41353143
DOI: 10.1186/s12882-[numero omesso]-0
License (as archived): solo-consultazione
Archived: 2026-11-07T21:10:25.041Z
SHA-256 of the archived text: cc591f0e791b6a73331acc13e5c2f69e05d831cdf54761e80a9714eabdf70587
Stable URL of this page: https://metraipolis.com/documento/dc_fcff41cee85d

How to cite

The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes — Europe PMC PMID:41353143 — Europe PMC (en), https://europepmc.org/article/MED/41353143 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcff41cee85d (Metraipolis archive dc_fcff41cee85d, sha256 cc591f0e791b6a73331acc13e5c2f69e05d831cdf54761e80a9714eabdf70587)

BibTeX

@misc{dcfcff41cee85d,
  title = {The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes — Europe PMC PMID:41353143},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41353143},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcff41cee85d; sha256 cc591f0e791b6a73331acc13e5c2f69e05d831cdf54761e80a9714eabdf70587},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41353143. Agents can read the archived copy with the MCP tool read_document.